Pharmacists and healthcare professionals operate in an increasingly complex medicines-information environment. Large Language Models (LLMs) and AI offer powerful tools to reduce information burden — but only when grounded in authoritative, regulated, and continuously updated data. This article explores how responsible AI, built on myHealthbox medicines information, can safely support clinical decision-making without replacing professional judgement.

Every day, pharmacists, doctors, and other healthcare professionals (HCPs) make critical decisions under significant time pressure, balancing patient safety, regulatory compliance, and operational efficiency.
Key challenges include:
As a result, HCPs may spend 30–40% of their time searching for and verifying medicines information.
Large Language Models are trained on vast volumes of text to recognise patterns in human language. Rather than retrieving predefined answers, they generate responses probabilistically based on context.
In healthcare, this means:
For medicines information, strong constraints, domain-specific grounding, and regulatory oversight are essential.
AI systems in healthcare broadly fall into three categories:
PharmaCopilot by myHealthbox is a decision-support system.
It supports pharmacists with information retrieval and interpretation — it does not make clinical decisions.
False or misleading outputs
Generative AI can produce plausible but incorrect responses. Verification remains essential.
Data bias
AI may reflect gaps or bias in training data, potentially skewing outputs.
Patient confidentiality
Decision-support systems often require sensitive patient information, making data protection and GDPR compliance critical.
Medicines information is highly regulated. Patient safety depends on accuracy, consistency, and regulatory alignment.
AI systems in this domain must rely on:
Using unofficial or unverified sources introduces unacceptable clinical and regulatory risk.
myHealthbox maintains an extensive, curated repository of official medicines information.
PharmaCopilot uses AI as an access and interpretation layer, not as an independent decision-maker:
This reduces information burden without compromising safety or compliance.

AI does not make medicines information safer.
Authoritative data, governance, and transparency do.
These characteristics align with emerging EU requirements for high-risk AI systems in healthcare.
Complex medication review
Natural-language queries identify interactions, contraindications, and counselling points, all linked to official sources.
Shortage management
Therapeutic alternatives are surfaced with authorised indications and dosing guidance.
Multilingual patient communication
Patient-friendly explanations in preferred languages alongside professional summaries.
Regulatory awareness
Concise updates on recalls, safety alerts, and labelling changes.
Effective safeguards include:
For patients
For healthcare professionals
Artificial Intelligence
Health data governance
Privacy and data protection
Medicines regulation